Quetiapine in tardive dyskinesia

International Journal of Psychiatry in Clinical Practice

Volumn 6, Issue 3, 2002, Pages 175-177

  Chari, Suresh ^a   Jainer, A K ^a   Ashley Smith, Andrew ^a   Cleaver, Maxine ^a  

^a ST MICHAEL'S HOSPITAL   (United Kingdom)

Author keywords

Atypical antipsychotics; Quetiapine; Seroquel; Tardive dyskinesia

Indexed keywords

CLOZAPINE; FLUPENTIXOL DECANOATE; NEUROLEPTIC AGENT; QUETIAPINE;

ADULT; AGRANULOCYTOSIS; ARTICLE; CASE REPORT; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MEDICOLEGAL ASPECT; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOIDISM; SCHIZOPHRENIA; SOCIAL INTERACTION; TARDIVE DYSKINESIA;

EID: 0036733419     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.1080/136515002760276126     Document Type: Article

References (16)

1. Uhrbrand L, Faurbye A (1960) Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and ECT. Psychopharmacologia 1: 408-18.
2. Bazire S (2000) Psychotropic Drug Directory 2000: A professionals' pocket handbook and aide memoire. Mark Allen Publishing, Dinton, 82.
3. Jeste DV, Caliguri MP, Paulsen JS et al (1993) Tardive dyskinesia. Schizophrenia Bull 19: 305-15.
4. Jeste DV, Caliguri MP, Paulsen JS et al (1995) Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients. Arch Gen Psychiatry 52: 756-65.
5. American Psychiatric Association (1992) Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association. APA, Washington, DC.
6. van Harten PN, Hoek HW Matroos GE et al (1998) Intermittent neuroleptic treatment and risk for tardive dyskinesia: The Curacao extrapyramidal syndrome study. III. Am J Psychiatry 155: 565-7.
7. Carlsson A (1970) Biochemical implications of dopa-induced actions on the central nervous system with particular reference to abnormal movements. In: L-Dopa and Parkinsonism (eds A Barbeau & FH McDowell). Davis, Philadelphia.
8. Guy W (1976) Assessment Manual for Psychopharmacology (revised). Washington DC: Department of Health, Education, and Welfare. Early Clinical Drug Evaluation Unit.
9. Lieberman JA, Saltz BL, Johns CA et al (1991) The effects of clozapine on tardive dyskinesia. Br J Psychiatry 158: 503-10.
10. Farah A (2001) Reduction of tardive dyskinesia with quetiapine. Schizophrenia Res 47: 309-10.
11. Vesely C, Kufferle B, Brucke T et al (2000) Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine. Int Clin Psychopharmacol 15: 57-60.
12. Almeida OP (1998) Olanzapine for the treatment of tardive dyskinesia. J Clin Psychiatry 59: 380-1.
13. O'Brien J, Barber R (1998) Marked improvement in tardive dyskinesia following treatment with olanzapine in an elderly subject. Br J Psychiatry 172: 186-9.
14. Rangwani SR, Gupta S, Burke WJ et al (1996) Improvement of debilitating tardive dyskinesia with risperidone. Ann Clin Psychiatry 8: 27-9.
15. Kooptiwoot S, Settachan T (2000) Improvement of tardive dyskinesia with risperidone. A case report. J Med Assoc Thailand 83: 1430-2.
16. Morgenstern H, Glazer WM (1993) Identifying risk factors for tardive dyskinesia among long term outpatients maintained with neuroleptic medications. Results of the Yale tardive dyskinesia study. Arch Gen Psychiatry 50: 723-33.